Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Winning ETF Strategies for the Second Half
- RTI: What Will the Fed Do Wednesday?
- RTI: Hey Homies - BULL Is the Word!
- Tech Roundup: GOOG Shows Mettle, AAPL in Freefall
- Home-Run Retailers
- Are Housing ETFs Back on Track?
- Buy Your Favorite Brands with These 3 Stocks
- What's a Global Investor to Do?
- 5 Careful Ways to Win with Options
- AWS 6/17: The Fed in Focus This Week
- PFP 6/17: Why Ask Why?
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 06/17/2013
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Accenture Plc’s (ACN - Snapshot Report) acquisition-driven growth strategy remains on track with the company recently acquiring a digital production services vendor avVenta Worldwide. Accenture closed the acquisition without disclosing the terms of the agreement.
The digital production services offered by Accenture to the chief marketing officers (CMOs) with the help of Accenture Interactive will be augmented following the integration of avVenta’s digital production solutions. Accenture will be using avVenta’s delivery center in San Jose to provide cost effective solutions to clients.
To be more specific, customers will benefit from the marriage of the digital production facility from avVentas digital production platform and other design processes offered by Accenture’s Interactive marketing operations. As a result, CMOs are expected to reap higher returns from their investments in marketing activities.
Moreover, the avVenta acquisition will provide Accenture with instant access to the former’s experienced staff along with the list of 130 Fortune 500 clients spread across the pharmaceutical, financial services and consumer packaged goods industries.
Earlier this month, Accenture wrapped up the acquisition of Octagon Research Solutions Inc., a reputed software solutions provider into the life sciences market. The company also picked up the Singapore-based distributor management and mobility software company NewsPage Pte Ltd. in late August.
The NewsPage Pte Ltd. acquisition is expected to strengthen the Accenture CAS software platform, which assists in the sales procedure of companies in the consumer goods industry, particularly with respect to their distributor management.
We believe that improvement in the order book along with recovery in the financial services market may have a positive impact on revenue going forward.
We are encouraged by Accenture’s strategy to grow through acquisitions. However, increasing competition from IBM Corp. (IBM - Analyst Report), a strained spending environment and Accenture’s broad European exposure (roughly 40.0%) may impact its growth prospects to some extent.
The company has a Zacks #2 Rank, implying a short-term Buy rating.
Get the full Snapshot Report on ACN - FREE
Get the full Analyst Report on IBM - FREE